Hikma Pharmaceuticals diskutieren
Hikma Pharmaceuticals
WKN: A0HG69 / Symbol: HKMPF / Name: Hikma Pharma / Aktie / Pharmazeutika / Mid Cap /
19,26 €
0,89 %
Hikma Pharmaceuticals PLC (OTCMKTS: HKMPF) is now covered by analysts at BNP Paribas. They set an "outperform" rating on the stock.
Ratings data for HKMPF provided by MarketBeat
Hikma Pharmaceuticals (OTCMKTS:HKMPF) was downgraded by analysts at Barclays PLC to an "underweight" rating.
Ratings data for HKMPF provided by MarketBeat
Hikma Pharmaceuticals (HKMPF) had its "buy" rating reaffirmed by Citigroup Inc..
Ratings data for HKMPF provided by MarketBeat


Neueste Beiträge
DZ_Bank_AG in K+S AG diskutieren, K+S AG